Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumorsCancer Chemotherapy and Pharmacology.  83:551-559. 2019
2019 Accurate Therapeutic Response Assessment of Pancreatic Ductal Adenocarcinoma Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging with a Point-of-Care Perfusion Phantom: A Pilot StudyInvestigative Radiology.  54:16-22. 2019
2017 2017 ASCO Highlights on Gastointestinal MalignanciesIndian Journal of Medical and Paediatric Oncology.  38:516-519. 2017
2016 Focused update on Gastrointestinal (GI) Oncology from ASCO 2016Indian Journal of Medical and Paediatric Oncology.  37:314-318. 2016
2016 Cisplatin- Versus Non–Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative CisplatinClinical Genitourinary Cancer.  14:331-340. 2016
2016 Extramedullary Involvement by Chronic Myelogeneous Leukemia in Five Patients With Unusual Clinicopathologic Features: A Review of the Effectiveness of Tyrosine Kinase Inhibitors.Journal of Clinical Medicine Research.  8:480-485. 2016
2015 Unique presentation of blastic plasmacytoid dendritic cell neoplasm: A single-center experience and literature reviewHematological Oncology.  33:206-211. 2015
2015 Effect of African-American Race on Tumor Recurrence after Radical Cystectomy for Urothelial Carcinoma of the BladderClinical Genitourinary Cancer.  13:469-475. 2015
2014 Clinicopathological and molecular features of myeloid sarcoma as initial presentation of therapy-related myeloid neoplasms: a single institution experienceInternational Journal of Hematology.  100:457-463. 2014
2013 Venous thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A systematic review and meta-analysis of randomized clinical trialsCritical Reviews in Oncology/Hematology.  87:80-89. 2013

Principal Investigator On

  • Private Grant  awarded by MINNEAMRITA THERAPEUTICS, LLC 2018 - 2023
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2018 - 2023
  • Private Grant  awarded by BOSTON BIOMEDICAL, INC. 2017 - 2022
  • Private Grant  awarded by MedImmune 2019 - 2022
  • Private Grant  awarded by TRACON PHARMACEUTICALS, INC. 2016 - 2021
  • Private Grant  awarded by HALOZYME, INC. 2016 - 2021
  • Private Grant  awarded by MOMENTA PHARMACEUTICALS, INC. 2016 - 2020
  • Private Grant  awarded by GLOBEIMMUNE, INC. 2016 - 2020
  • Private Grant  awarded by BIOCARTIS US INC. 2018 - 2019
  • Private Grant  awarded by REXAHN PHARMACEUTICALS, INC. 2016 - 2018
  • Private Grant  awarded by NEWLINK GENETICS, INC 2016 - 2017
  • Investigator On

  • Private Grant  awarded by CALITHERA BIOSCIENCES INC 2019 - 2024
  • Private Grant  awarded by PUMA BIOTECHNOLOGY, INC. 2019 - 2024
  • Private Grant  awarded by CELGENE CORPORATION 2019 - 2024
  • Private Grant  awarded by ROCHE TCRC, INC. 2018 - 2023
  • Private Grant  awarded by Sanofi US Services Inc 2018 - 2023
  • Private Grant  awarded by INCYTE CORPORATION 2018 - 2023
  • Private Grant  awarded by INCYTE CORPORATION 2018 - 2023
  • Private Grant  awarded by INCYTE CORPORATION 2018 - 2023
  • Private Grant  awarded by MERCK & COMPANY, INC. 2019 - 2023
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2018 - 2023
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2017 - 2022
  • Private Grant  awarded by TRACON PHARMACEUTICALS, INC. 2017 - 2022
  • Private Grant  awarded by TRACON PHARMACEUTICALS, INC. 2019 - 2022
  • Private Grant  awarded by SEATTLE GENETICS, INC. 2017 - 2022
  • Private Grant  awarded by INCYTE CORPORATION 2017 - 2022
  • Private Grant  awarded by SEATTLE GENETICS, INC. 2017 - 2022
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2016 - 2021
  • Private Grant  awarded by ELI LILLY AND COMPANY 2016 - 2021
  • Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response  awarded by National Cancer Institute/NIH/DHHS 2019 - 2021
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2016 - 2021
  • Private Grant  awarded by NAVIDEA BIOPHARMACEUTICALS, INC. 2017 - 2020
  • Private Grant  awarded by ELI LILLY AND COMPANY 2015 - 2020
  • Private Grant  awarded by MIRATI THERAPEUTICS, INC. 2015 - 2020
  • Alliance for Clinical Trials in Oncology Payment Agreement  awarded by MAYO CLINIC 2017 - 2020
  • Private Grant  awarded by INCYTE CORPORATION 2015 - 2020
  • ECOG-ACRIN Purchase Service Agreement  awarded by Eastern Cooperative Oncology Group 2014 - 2020
  • Southwest Oncology Group Purchase Service Agreement  awarded by Oregon Health & Science University 2015 - 2020
  • Private Grant  awarded by AILERON THERAPEUTICS 2015 - 2020
  • UAB 1764:The Targeted Agent and Profiling Utilization Registry (TAPUR) Study  awarded by American Society of Clinical Oncology 2017 - 2019
  • Private Grant  awarded by INCYTE CORPORATION 2018 - 2019
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2017 - 2019
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2017 - 2019
  • Private Grant  awarded by BIOCOMPATIBLES UK LTD 2016 - 2018
  • Private Grant  awarded by REXAHN PHARMACEUTICALS, INC. 2016 - 2017
  • Private Grant  awarded by HALOZYME, INC. 2016
  • Private Grant  awarded by MOMENTA PHARMACEUTICALS, INC. 2015 - 2016
  • Private Grant  awarded by AILERON THERAPEUTICS 2015
  • Education And Training

  • Bachelor of Medicine & Surgery (MBBS), Kakatiya University 2007
  • UAB Hospital, Residency 2012
  • UAB Hospital, Postdoctoral Fellowship 2015
  • Full Name

  • Ravi Paluri